To better decipher the links between primary RCCs and their corresponding metastases at cellular level, we performed laser microdissection to select p53-expressing cells and study their mutational profile for TP53. In the metastatic sample of one patient, we demonstrated the expansion of a TP53 mutated clone which was a minority in the primary RCC. Here, TP53 is linked to renal cell carcinoma.